2,5-Dimethoxy-4-methylphenylcyclopropylamine

2,5-Dimethoxy-4-methylphenylcyclopropylamine (DMCPA) is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 15–20 mg and the duration is listed as 4–8 hours. DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. Shulgin gives it a +++ on the Shulgin Rating Scale.

United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.

Pharmacology
Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.